The proceeds will support the advancement of STC-15 in a Phase 2 study in select sarcoma indicationsFirst‑in‑class METTL3 inhibitor reprograms ...
Are you struggling with extreme hair fall even after undergoing expensive treatments? Dermatologist explains why sometimes ...
In PCOS management, inositol acts as an insulin sensitiser. It helps improve the body's response to insulin, which plays a ...
STORM Therapeutics, a Cambridge-based clinical stage company targeting RNA modifications to reprogram cells and develop novel ...
A Mondelēz-backed startup hits a breakthrough that could change chocolate forever.
Based on on-site visits to the 2026 China Hydrogen Energy Exhibition and International Hydrogen Energy Conference, the most intuitive impression of this edition was that the industry as a whole is ...
TORONTO, April 16, 2026 /CNW/ - Celestial Acquisition Corp. (TSXV: CES.P) ("Celestial"), a space technology focused capital pool company, is pleased to announce that it has entered into a Business ...
The United Kingdom has long been a powerhouse in the pharmaceutical and biotechnology sectors, but recent developments have ...
De-addiction centres in Delhi are raising serious concerns, with recent violent incidents highlighting their failure to ...
Cells are enveloped by a lipid membrane that gives them structure and provides a barrier between the cell and its environment ...
As we age, our ability to maintain healthy blood and a strong immune system gradually declines, largely because hematopoietic ...
BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results